AstraZeneca (AZN)

Add to Watchlists
Create an Alert
29.08 -0.10  -0.34% NYSE Aug 17, 16:59 Delayed 2m USD

AstraZeneca Return on Equity (TTM):

24.50% for March 31, 2017
View 4,000+ financial data types
Browse...
View Full Chart

AstraZeneca Return on Equity (TTM) Chart

Export Data
Save Image
Print Image

AstraZeneca Historical Return on Equity (TTM) Data

View and export this data going back to 1993. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2017 24.50%
Dec. 31, 2016 23.42%
Sept. 30, 2016 15.97%
June 30, 2016 13.48%
March 31, 2016 17.02%
Dec. 31, 2015 15.58%
Sept. 30, 2015 9.15%
June 30, 2015 6.06%
March 31, 2015 6.36%
Dec. 31, 2014 5.77%
Sept. 30, 2014 4.66%
June 30, 2014 8.93%
March 31, 2014 9.03%
Dec. 31, 2013 11.04%
Sept. 30, 2013 20.03%
June 30, 2013 21.41%
March 31, 2013 25.21%
Dec. 31, 2012 27.72%
Sept. 30, 2012 27.58%
June 30, 2012 35.80%
March 31, 2012 37.95%
Dec. 31, 2011 42.90%
Sept. 30, 2011 43.91%
June 30, 2011 36.11%
March 31, 2011 37.03%
   
Dec. 31, 2010 37.00%
Sept. 30, 2010 38.02%
June 30, 2010 42.48%
March 31, 2010 43.38%
Dec. 31, 2009 42.18%
Sept. 30, 2009 42.65%
June 30, 2009 42.08%
March 31, 2009 43.18%
Dec. 31, 2008 39.37%
Sept. 30, 2008 40.16%
June 30, 2008 38.25%
March 31, 2008 38.00%
Dec. 31, 2007 38.09%
Sept. 30, 2007 39.27%
June 30, 2007 40.77%
March 31, 2007 42.65%
Dec. 31, 2006 41.89%
Sept. 30, 2006 41.62%
June 30, 2006 39.71%
March 31, 2006 37.67%
Dec. 31, 2005 34.45%
Sept. 30, 2005 31.88%
June 30, 2005 31.27%
March 31, 2005 28.35%
Dec. 31, 2004 26.76%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Advertisement

AZN Return on Equity (TTM) Benchmarks

Companies
GlaxoSmithKline 120.6%
Johnson & Johnson 22.82%
Eli Lilly 14.92%

AZN Return on Equity (TTM) Range, Past 5 Years

Minimum 4.66% Sep 2014
Maximum 27.72% Dec 2012
Average 15.42%

AZN Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("AZN", "return_on_equity")
  • Last 5 data points: =YCS("AZN", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.